Mitsubishi UFJ Trust & Banking
DNA icon

Mitsubishi UFJ Trust & Banking’s Ginkgo Bioworks DNA Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-91,818
Closed -$4.26M – 1106
2024
Q1 		$4.26M Sell
91,818
-5,963
-6% -$309K 0.01% 706
2023
Q4 		$6.61M Sell
97,781
-5,144
-5% -$315K 0.02% 640
2023
Q3 		$7.45M Sell
102,925
-7,097
-6% -$567K 0.02% 609
2023
Q2 		$8.19M Sell
110,022
-7,989
-7% -$473K 0.02% 596
2023
Q1 		$6.28M Buy
118,011
+21,918
+23% +$1.39M 0.02% 638
2022
Q4 		$6.5M Buy
96,093
+1,415
+1% +$130K 0.02% 631
2022
Q3 		$11.8M Sell
94,678
-822
-0.9% -$98K 0.03% 479
2022
Q2 		$9.09M Buy
95,500
+63,854
+202% +$7.79M 0.02% 566
2022
Q1 		$5.1M Buy
31,646
+3,895
+14% +$758K 0.01% 697
2021
Q4 		$9.22M Buy
27,751
+25,873
+1,378% +$12.3M 0.02% 614
2021
Q3 		$871K Buy
+1,878
New +$914K ﹤0.01% 953

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's DNA Position: Q2 2024 in Review

Mitsubishi UFJ Trust & Banking sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 91,818 shares — an estimated $4.26M sold.

Mitsubishi UFJ Trust & Banking first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $11.8M in Q3 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Mitsubishi UFJ Trust & Banking reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 91,818 Ginkgo Bioworks shares in Q2 2024, an estimated $4.26M.
  • Mitsubishi UFJ Trust & Banking first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
  • Mitsubishi UFJ Trust & Banking's Ginkgo Bioworks position peaked at $11.8M in Q3 2022.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2024, filed 8 Aug 2024.